Back to search

Article

Evaluation of the Blood and Serum Biomarkers for the Prognosis and Progression of the ALS Disease by Eliminating the Effects of Aging

2022-03-14

Abstract excerpt

Amyotrophic Lateral Sclerosis (ALS) is the most common motor neuron disease. There are no pathognomonic tests for ALS prognosis; clinical diagnosis of the disease takes time and is usually difficult. Prognostic biomarkers are urgently needed for rapid and effective ALS prognosis. Male albino rats were divided into ten groups based on age as 0 (40–45 days old), A (70–75 days old), B (90–95 days old), C (110–115 day...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5b2d8132-42f5-5c67-bb39-d9673a620481
DOI
10.21203/rs.3.rs-1427688/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluation of the Blood and Serum Biomarkers for the Prognosis and Progression of the ALS Disease by Eliminating the Effects of AgingDOI 10.21203/rs.3.rs-1427688/v1
Select a neighboring publication to make it the new centre.